GlassScriptPhysician profile
Heather Wells
NPI 1598306227
$6,865.51
in general payments reported to CMS, 2019-2025
40 companies · $1,786 in 2025
The $1,786 reported for 2025 was more than what 94% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,117 · 2022: $1,340 · 2023: $1,011 · 2024: $1,612 · 2025: $1,786.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,176 · Education: $233.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,175.58 |
| Education | $233.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,626.25 | 2021-2025 | |
| Pfizer INC. | $649.44 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $599.79 | 2022-2025 | Breztri, Airsupra, Farxiga |
| Janssen Pharmaceuticals, INC | $490.91 | 2021-2024 | Xarelto |
| Harmony Biosciences LLC | $391.02 | 2021-2025 | Wakix |
| Biohaven Pharmaceutical Holding Company LTD. | $225.01 | 2022 | |
| Glaxosmithkline, LLC. | $209.67 | 2021-2024 | Arexvy, Trelegy Ellipta |
| Amgen INC. | $202.70 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $147.41 | 2021-2024 | Jardiance |
| Grifols USA, LLC | $144.79 | 2021-2024 | Prolastin-C Liquid |
| Mallinckrodt Hospital Products INC. | $126.77 | 2021-2022 | |
| Actelion Pharmaceuticals US, INC. | $108.62 | 2021-2022 | |
| Irhythm Technologies, INC. | $95.24 | 2024 | Zio Monitor, Zio Xt Patch |
| Baxter Healthcare | $78.15 | 2023-2024 | Hillrom - Monarch Airway Clearance System, Hillrom - Life 2000 Ventilation System |
| Novo Nordisk INC | $74.52 | 2021-2024 | Rybelsus, Ozempic |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Wells listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.